Battistin L - Search Results

1

Alterations of striatal dopamine D2 receptors contribute to deteriorated response to L-dopa in Parkinson's disease: a [123I]-IBZM SPET study.

Pizzolato G, Chierichetti F, Rossato A, Cagnin A, Fabbri M, Dam M, Ferlin G, Battistin L. Pizzolato G, et al. Among authors: battistin l. J Neural Transm Suppl. 1995;45:113-22. J Neural Transm Suppl. 1995. PMID: 8748616

2

Dopamine receptor SPET imaging in Parkinson's disease: a [123I]-IBZM and [99mTc]-HM-PAO study.

Pizzolato G, Chierichetti F, Rossato A, Briani C, Dam M, Borsato N, Saitta B, Zanco P, Ferlin G, Battistin L. Pizzolato G, et al. Among authors: battistin l. Eur Neurol. 1993;33(2):143-8. doi: 10.1159/000116921. Eur Neurol. 1993. PMID: 8467821

3

Striatal dopamine D2 receptor alterations and response to L-DOPA in Parkinson's disease. A [123I]IBZM SPET study.

Pizzolato G, Cagnin A, Rossato A, Chierichetti F, Fabbri M, Dam M, Ferlin G, Battistin L. Pizzolato G, et al. Among authors: battistin l. Adv Neurol. 1996;69:467-73. Adv Neurol. 1996. PMID: 8615167 Clinical Trial. No abstract available.

4

Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZM.

Pizzolato G, Chierichetti F, Fabbri M, Cagnin A, Dam M, Ferlin G, Battistin L. Pizzolato G, et al. Among authors: battistin l. Neurology. 1996 Oct;47(4):1065-8. doi: 10.1212/wnl.47.4.1065. Neurology. 1996. PMID: 8857746

5

A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials.

Freo U, Pizzolato G, Dam M, Ori C, Battistin L. Freo U, et al. Among authors: battistin l. J Neural Transm (Vienna). 2002 May;109(5-6):857-70. doi: 10.1007/s007020200070. J Neural Transm (Vienna). 2002. PMID: 12111473 Review.

6

Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade.

Briani C, Cagnin A, Chierichetti F, Tiberio M, Battistin L, Pizzolato G. Briani C, et al. Among authors: battistin l. Eur J Neurol. 2004 Oct;11(10):709-10. doi: 10.1111/j.1468-1331.2004.00844.x. Eur J Neurol. 2004. PMID: 15469457

7

Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine.

Battistin L, Pizzolato G, Dam M, Da Col C, Perlotto N, Saitta B, Borsato N, Calvani M, Ferlin G. Battistin L, et al. Eur Neurol. 1989;29(5):261-5. doi: 10.1159/000116423. Eur Neurol. 1989. PMID: 2792144

8

[99mTc]-HM-PAO SPECT in Parkinson's disease.

Pizzolato G, Dam M, Borsato N, Saitta B, Da Col C, Perlotto N, Zanco P, Ferlin G, Battistin L. Pizzolato G, et al. Among authors: battistin l. J Cereb Blood Flow Metab. 1988 Dec;8(6):S101-8. doi: 10.1038/jcbfm.1988.39. J Cereb Blood Flow Metab. 1988. PMID: 3263976

9

Metabolic aspects of aging brain and related disorders.

Battistin L, Rigo A, Bracco F, Dam M, Pizzolato G. Battistin L, et al. Gerontology. 1987;33(3-4):253-8. doi: 10.1159/000212886. Gerontology. 1987. PMID: 3498665

10

Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results.

Frisoni GB, Pizzolato G, Bianchetti A, Chierichetti F, Ferlin G, Battistin L, Trabucchi M. Frisoni GB, et al. Among authors: battistin l. Acta Neurol Scand. 1994 Mar;89(3):199-203. doi: 10.1111/j.1600-0404.1994.tb01661.x. Acta Neurol Scand. 1994. PMID: 8030401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters